Odylia Therapeutics
Odylia utilizes a unique, nonprofit business model to accelerate the development of gene therapies for people with rare disease. Our ultimate goal is to bring life changing treatments to people with genetic disease, regardless of prevalence or commercial interest.
7-day free trial · no credit card
Verified contacts
9
available on Kipplo
LinkedIn employees
9
1 to 10 range
Open roles
—
no listings
Distinct roles
6
indexed titles
Tech stack
1
tools in use
Monthly traffic
133
organic / mo
Sign up free to see all 9 verified contacts at Odylia Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
9 contacts with verified email or phone · masked until revealed.
- AW
Ashley Winslow
Chief Executive Officer & Chief Scientific Officer · Other
EmailPhone - HH
Heather Hart Greene
Director of Development · Research & Development
EmailPhone - JK
Jennifer Klein
Director, Program Management and Operations · Other
EmailPhone
Showing 3 of 9 verified contacts
Top roles at Odylia Therapeutics
6 distinct titles indexed · top 6 shown.
- 2director, program management and operations
- 1chief executive officer & chief scientific officer
- 1director of development
- 1medical writer
- 1research collaborator
- 1scientist
Sign up to unlock all 9 contacts at Odylia Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 9 verified contacts at Odylia Therapeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.